Pharmaceuticals

Below are the top drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of dividend yield. Tianyin Pharmaceutical Co Inc (AMEX: TPI) has a dividend yield of 3.70%. TPI's shares closed at $2.67 yesterday. Reliv' International Inc (NASDAQ: RELV) has a dividend yield of 2.30%. RELV's...

Heska Corporation (Nasdaq: HSKA) today announced that, at the Company's Special Meeting of Stockholders held on December 29, 2010, the stockholders of Heska voted to approve a proposal to effect a 1-for-10 reverse stock split of the Company's issued and outstanding shares of common stock, together...

Heska Corporation (Nasdaq: HSKA) today announced that, at the Company's Special Meeting of Stockholders held on December 29, 2010, the stockholders of Heska voted to approve a proposal to effect a 1-for-10 reverse stock split of the Company's issued and outstanding shares of common stock, together...

We are maintaining our Neutral recommendation on Theravance Inc. (THRX) with a target price of $27. Theravance founded in 1996 and headquartered in South San Francisco, California focuses on the discovery, development and commercialization of small molecule medicines. The company develops...

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that the U.S. Food and Drug Administration has approved FORTESTA Gel for the treatment of low testosterone, or 'Low T,' also known as hypogonadism. Symptoms associated with Low T include erectile dysfunction and decreased sexual desire, fatigue...

We are maintaining our Neutral recommendation on Theravance Inc. (THRX) with a target price of $27. Theravance founded in 1996 and headquartered in South San Francisco, California focuses on the discovery, development and commercialization of small molecule medicines. The company develops...

Recently, Novo Nordisk (NVO) reported solid top-line results from three phase III studies of Degludec and two studies of DegludecPlus. Degludec significantly reduced the risk of hypoglycaemia during the night compared to Sanofi Aventis' (SNY) Lantus in two long-term studies. Degludec (also...

Cusick's Corner The market continued to whip around unchanged to slightly positive levels for the remainder day -- the March S&P settled at 1254.25. This type of action can be expected for a holiday week, plus throw in the snowstorm out East which left many traders at home. It's been a tough...

Recently, Novo Nordisk (NVO) reported solid top-line results from three phase III studies of Degludec and two studies of DegludecPlus. Degludec significantly reduced the risk of hypoglycaemia during the night compared to Sanofi Aventis' (SNY) Lantus in two long-term studies. Degludec (also...

Here is a quick peek at stocks that have abnormally high daily put/call ratios today relative to their average…. 1. Hercules Offshore (NASDAQ: HERO) 33,483 puts, 386 calls 2. Fastenal Co. (NASDAQ: FAST) 5,492 puts, 118 calls 3. Auxillium Pharmaceuticals (NASDAQ: AUXL) 5,009 puts, 222 calls 4....

Pfizer (NYSE: PFE) Animal Health today announced an agreement to acquire Synbiotics Corporation (Pink Sheets: SYNB). Synbiotics estimates that its common shareholders will be entitled to receive up to approximately $0.306 per share in cash in connection with the acquisition, of which approximately...

By 11:53 am, the Dow Jones Industrial Average was up 25.05 points, or 0.22%, to 11,600.59, while the broader Standard & Poor's 500 index had gained 2.38 points, or 0.19%. The NASDAQ composite index rose 4.89 points, or 0.18%. Some of the narrow based indexes driving the markets are Rare Earth...

Cephalon Inc. (CEPH) recently announced that it no longer intends to pursue for the approval of Nuvigil for the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel. The company arrived at this decision following the receipt of a second...

Pulse Electronics Corporation (NYSE: PULS) jumped 24.77% to $5.44 at 10:00 am. PULS reported that it has received a letter from Bel Fuse Inc. China Shen Zhou Mining & Resources Inc (AMEX: SHZ) climbed 17.09% to $6.44. SHZ's trailing-twelve-month profit margin is 106.99%. Marshall Edwards Inc (...